{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:33:19Z","timestamp":1792758799692,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.bmcl.2004.12.016","type":"journal-article","created":{"date-parts":[[2005,1,8]],"date-time":"2005-01-08T23:55:22Z","timestamp":1105228522000},"page":"1101-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)"],"prefix":"10.1016","volume":"15","author":[{"given":"Soong-Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Pudzianowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2004.12.016_bib1_1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1367-5931(98)80122-1","volume":"2","author":"Johnson","year":"1998","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bmcl.2004.12.016_bib1_2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0955-0674(98)80035-5","volume":"10","author":"Shapiro","year":"1998","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bmcl.2004.12.016_bib1_3","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","volume":"9","author":"Whittaker","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bmcl.2004.12.016_bib1_4","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmcl.2004.12.016_bib2_1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780340905","volume":"34","author":"Firestein","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bmcl.2004.12.016_bib2_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.1780350106","volume":"35","author":"Walakovits","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bmcl.2004.12.016_bib2_3","first-page":"16","volume":"2","author":"Clark","year":"2000","journal-title":"Curr. Opin. Anti-Inflam. Immunomod. Invest. Drugs"},{"key":"10.1016\/j.bmcl.2004.12.016_bib2_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/14756369809035829","volume":"13","author":"Bottomley","year":"1998","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bmcl.2004.12.016_bib2_5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1006386406584","volume":"17","author":"Yip","year":"1999","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bmcl.2004.12.016_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/ard.58.6.357","volume":"58","author":"Freemont","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bmcl.2004.12.016_bib4_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI10564","volume":"1","author":"Neuhold","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bmcl.2004.12.016_bib4_2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ard.58.11.691","volume":"58","author":"Konttinen","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bmcl.2004.12.016_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/0929867013373417","volume":"8","author":"Skiles","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bmcl.2004.12.016_bib6_1","series-title":"Metalloproteinases as Targets for Anti-Inflammatory Drugs","first-page":"17","author":"Skotnicki","year":"1999"},{"key":"10.1016\/j.bmcl.2004.12.016_bib6_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14728222.7.1.19","volume":"7","author":"Clark","year":"2003","journal-title":"Exp. Opin. Ther. Targets"},{"key":"10.1016\/j.bmcl.2004.12.016_bib7","unstructured":"Campbell, J. A. Book of Abstracts, 216th ACS National Meeting of the American Chemical Society, 1998"},{"key":"10.1016\/j.bmcl.2004.12.016_bib8_1","unstructured":"Bender, S. Lecture at the Second Winter Conference on Medicinal Chemistry, Steamboat Springs, CO, Jan 26\u201331, 1997"},{"key":"10.1016\/j.bmcl.2004.12.016_bib8_2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/jm9707582","volume":"41","author":"Tamura","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2004.12.016_bib8_3","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bmcl.2004.12.016_bib9","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/13543784.9.7.1469","volume":"9","author":"Shaw","year":"2000","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.bmcl.2004.12.016_bib10_1","unstructured":"Barbituric acids: Oliva, A.; De Cellis, G.; Grams, F.; Livi, V.; Zimmermann, G.; Menta, E.; Krell, H. -W., PCT Int. Appl. WO 9858925, Dec 30, 1998"},{"key":"10.1016\/j.bmcl.2004.12.016_bib10_2","unstructured":"Grams, F.; Mermann, G. PCT Int. Appl. WO 9858915, Dec 30, 1998"},{"key":"10.1016\/j.bmcl.2004.12.016_bib10c","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0960-894X(01)00104-4","volume":"11","author":"Foley","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2004.12.016_bib10d","doi-asserted-by":"crossref","first-page":"17405","DOI":"10.1074\/jbc.M007475200","volume":"20","author":"Brandstetter","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmcl.2004.12.016_bib10e","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1110\/ps.48401","volume":"10","author":"Dunten","year":"2001","journal-title":"Protein Sci."},{"key":"10.1016\/j.bmcl.2004.12.016_bib10_6","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1021\/ja0485513","volume":"126","author":"Puerta","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmcl.2004.12.016_bib10_7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/jm9803222","volume":"42","author":"Jacobsen","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2004.12.016_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1039\/c29710000290","volume":"7","author":"Wang","year":"1971","journal-title":"J. Chem. Soc., Chem. Commun."},{"key":"10.1016\/j.bmcl.2004.12.016_bib13","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/ja00299a024","volume":"107","author":"Dewar","year":"1985","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmcl.2004.12.016_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/6657","volume":"6","author":"Lovejoy","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bmcl.2004.12.016_bib16","series-title":"Host Guest Complex Chemistry","first-page":"1","author":"Cram","year":"1985"},{"key":"10.1016\/j.bmcl.2004.12.016_bib17_1","unstructured":"The available X-ray coordinates of 1 with MMP-1314 were used in the sybyl program to arrive at binding site descriptors, including mol2map surface grids that provide chemical probe interaction energy contours of the binding site. As shown in Figure 3, a tris-imidazole complex was used with the AM1 semiempirical SCF-MO methodology to examine zinc\u2013barbiturate interaction. The calculated Zn\u2013N barbiturate distance (2.09\u00c5) and geometric constraints (monodentate nitrogen chelation, tetrahedral L\u2013Zn\u2013L of 109.5\u00b0) were built into the Tripos molecular mechanics force field (Tripos FF). Inhibitor modeling was initiated with a SAM1 optimized structure of the inhibitor, for example, 4a, inserted into the MMP-13 binding site. The entire protein\/inhibitor aggregate was then allowed to relax for 1000 iterations of geometry optimization with the Tripos force field, resulting in the structure shown in Figure 4"},{"key":"10.1016\/j.bmcl.2004.12.016_bib17_2","unstructured":"sybyl: Tripos, Inc., 1699 S. Hanley Road, St. Louis MO 63144-2913"},{"key":"10.1016\/j.bmcl.2004.12.016_bib17_3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","volume":"28","author":"Goodford","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2004.12.016_bib17_4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","volume":"10","author":"Clark","year":"1989","journal-title":"J. Comp. Chem."},{"key":"10.1016\/j.bmcl.2004.12.016_bib17_5","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/S0040-4020(01)81868-8","volume":"23","author":"Dewar","year":"1993","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2004.12.016_bib19","first-page":"674","author":"Lam","year":"2000","journal-title":"Synlett"},{"key":"10.1016\/j.bmcl.2004.12.016_bib20","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/0960-894X(95)00330-V","volume":"5","author":"Copeland","year":"1995","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2004.12.016_bib21","series-title":"Metalloproteinases as Targets for Anti-Inflammatory Drugs","first-page":"17","author":"Borkakoti","year":"1999"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X04014751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X04014751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T05:29:55Z","timestamp":1760765395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X04014751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0960894X04014751"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2004.12.016","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2004.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}